Acute Ischemic Stroke study: ActivPAL device
Official title RIsE Stroke Mobility Study
ClinicalTrials.gov ID: NCT07638462
What this study is testing
- What it's testing
- The study aims to learn typical movement patterns early after a severe stroke and see how well patients meet mobility goals while in the hospital.
- Who it's for
- Adults who have had a severe acute ischemic stroke and are currently hospitalized.
- What's involved
- Participants will wear a small thigh‑mounted device (activPAL) that records activity, and researchers will use the usual mobility information collected during care. No extra treatment is given.
- Time commitment
- Involvement continues for the duration of the hospital stay, with daily monitoring and data collection.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- Adults aged 18 years and older
- Hospitalized patients with acute ischemic stroke
- Initial National Institutes of Health Stroke Scale (NIHSS) score of 10 or greater
- Baseline modified Rankin Scale (mRS) score of 0-2
- Current modified Rankin Scale (mRS) score of 3-5
You likely can't join if
- Current or expected End-of-life discussions
- Current plans for surgical intervention
- Patients with pre-mRS of 3-5
- Patients with orthopedic, musculoskeletal, integumentary injury that would prevent safe weight bearing, mobility or equipment use
- Uncontrolled cardiorespiratory dysfunction or disease
- Active/uncontrolled seizures
See the full eligibility criteria
- Adults aged 18 years and older
- Hospitalized patients with acute ischemic stroke
- Initial National Institutes of Health Stroke Scale (NIHSS) score of 10 or greater
- Baseline modified Rankin Scale (mRS) score of 0-2
- Current modified Rankin Scale (mRS) score of 3-5
- Current or expected End-of-life discussions
- Current plans for surgical intervention
- Patients with pre-mRS of 3-5
- Patients with orthopedic, musculoskeletal, integumentary injury that would prevent safe weight bearing, mobility or equipment use
- Uncontrolled cardiorespiratory dysfunction or disease
- Active/uncontrolled seizures
- Isolation status that would prevent mobility outside of the room
- Weight that exceeds the safe limits of mobility equipment
The study team makes the final eligibility decision.
Where it is enrolling
- Winston-Salem, North Carolina, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part, but confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
This study is enrolling now at Winston-Salem, North Carolina, United States. Enter your location above to see the nearest enrolling site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool that is independent of the study sponsor. Details come from ClinicalTrials.gov. The study team decides eligibility, and your own doctor gives medical advice.